Tandavanitj, R., Setthapramote, C., De Lorenzo, G. , Sanchez-Velazquez, R., Clark, J. J., Rocchi, M., McInnes, C., Kohl, A. and Patel, A. H. (2024) Virus-like particles of louping ill virus elicit potent neutralizing antibodies targeting multimers of viral envelope protein. Vaccine, (doi: 10.1016/j.vaccine.2024.03.008) (In Press)

Ribeiro da Silva, S. J. et al. (2024) Development and field validation of an RT-LAMP assay for the rapid detection of chikungunya virus in patient and mosquito samples. Clinical Microbiology and Infection, (doi: 10.1016/j.cmi.2024.03.004) (PMID:38460820) (Early Online Publication)

Rainey, S. M., Lefteri, D. A. , Darby, C., Kohl, A. , Merits, A. and Sinkins, S. P. (2024) Evidence of differences in cellular regulation of Wolbachia-mediated viral inhibition between alphaviruses and flaviviruses. Viruses, 16(1), 115. (doi: 10.3390/v16010115) (PMID:38257815) (PMCID:PMC10818798)

Gonzalo Nadal, V. et al. (2023) Suspected tick-borne flavivirus meningoencephalomyelitis in dogs from the UK: six cases (2021). Journal of Small Animal Practice, (doi: 10.1111/jsap.13682) (PMID:37956993) (Early Online Publication)

Leggewie, M. et al. (2023) The Aedes aegypti RNA interference response against Zika virus in the context of co-infection with dengue and chikungunya viruses. PLoS Neglected Tropical Diseases, 17(7), e0011456. (doi: 10.1371/journal.pntd.0011456) (PMID:37440582) (PMCID:PMC10343070)

Ribeiro da Silva, S. J., Kohl, A. , Pena, L. and Pardee, K. (2023) Clinical and laboratory diagnosis of monkeypox (mpox): current status and future directions. iScience, 26(6), 106759. (doi: 10.1016/j.isci.2023.106759) (PMID:37206155) (PMCID:PMC10183700)

Laureti, M., Lee, R.-L., Bennett, A., Wilson, L. A., Sy, V. E., Kohl, A. and Dietrich, I. (2023) Rift Valley Fever Virus primes immune responses in Aedes aegypti cells. Pathogens, 12(4), 563. (doi: 10.3390/pathogens12040563) (PMID:37111448) (PMCID:PMC10146816)

Pondeville, E. et al. (2023) Infravec2 guidelines for the design and operation of containment level 2 and 3 insectaries in Europe. Pathogens and Global Health, 117(3), pp. 293-307. (doi: 10.1080/20477724.2022.2108639) (PMID:35996820) (PMCID:PMC10081053)

Mancini, M. V. et al. (2023) Evaluation of an engineered Zika virus-like particle vaccine candidate in a mosquito-mouse transmission model. mSphere, 8(2), e00564-22. (doi: 10.1128/msphere.00564-22) (PMID:36840596) (PMCID:PMC10117074)

Alexander, A. J.T. et al. (2023) Characterisation of the antiviral RNA interference response to Toscana virus in sand fly cells. PLoS Pathogens, 19(3), e1011283. (doi: 10.1371/journal.ppat.1011283) (PMID:36996243) (PMCID:PMC10112792)

Ribeiro da Silva, S. J., Kohl, A. , Pena, L. and Pardee, K. (2023) Recent insights into SARS‐CoV‐2 omicron variant. Reviews in Medical Virology, 33(1), e2373. (doi: 10.1002/rmv.2373) (PMID:35662313) (PMCID:PMC9347414)

Ayers, V. B., Huang, Y.-J. S., Dunlop, J. I., Kohl, A. , Brennan, B. , Higgs, S. and Vanlandingham, D. L. (2023) Immunogenicity of a candidate live attenuated vaccine for Rift Valley fever virus with a two-segmented genome. Viral Immunology, 36(1), pp. 33-40. (doi: 10.1089/vim.2022.0104) (PMID:36399689) (PMCID:PMC9885543)

Ayers, V. B., Huang, Y.-J. S., Kohl, A. , Dunlop, J. I., Hettenbach, S. M., Park, S. L., Higgs, S. and Vanlandingham, D. L. (2023) Comparison of immunogenicity between a candidate live attenuated vaccine and an inactivated vaccine for Cache Valley virus. Viral Immunology, 36(1), pp. 41-47. (doi: 10.1089/vim.2022.0103) (PMID:36622942) (PMCID:PMC9885547)

Ayers, V. B., Huang, Y.-J. S., Dunlop, J. I., Kohl, A. , Brennan, B. , Higgs, S. and Vanlandingham, D. L. (2022) Replication kinetics of a candidate live-attenuated vaccine for Cache Valley virus in Aedes albopictus. Vector-Borne and Zoonotic Diseases, 22(11), pp. 553-558. (doi: 10.1089/vbz.2022.0053) (PMID:36354965) (PMCID:PMC9700352)

da Silva, S. J. R. et al. (2022) Two years into the COVID-19 pandemic: lessons learned. ACS Infectious Diseases, 8(9), pp. 1758-1814. (doi: 10.1021/acsinfecdis.2c00204) (PMID:35940589) (PMCID:PMC9380879)

Bamford, C. G.C., Aranday-Cortes, E. , Sanchez-Velazquez, R., Mullan, C., Kohl, A. , Patel, A. H. , Wilson, S. J. and McLauchlan, J. (2022) A human and rhesus macaque interferon-stimulated gene screen shows that over-expression of ARHGEF3/XPLN inhibits replication of hepatitis C virus and other flavivirids. Viruses, 14(8), 1655. (doi: 10.3390/v14081655) (PMID:36016278) (PMCID:PMC9414520)

Crawford, C. L. et al. (2022) SARM1 depletion slows axon degeneration in a CNS model of neurotropic viral infection. Frontiers in Molecular Neuroscience, 15, 860410. (doi: 10.3389/fnmol.2022.860410) (PMID:35493328) (PMCID:PMC9043327)

Bryden, S. R. et al. (2022) Exploration of immunological responses underpinning severe fever with thrombocytopenia syndrome virus infection reveals IL-6 as a therapeutic target in an immunocompromised mouse model. PNAS Nexus, 1(1), pgac024. (doi: 10.1093/pnasnexus/pgac024) (PMID:35529317) (PMCID:PMC9071185)

Grass, V. et al. (2022) Adaptation to host cell environment during experimental evolution of Zika virus. Communications Biology, 5, 1115. (doi: 10.1038/s42003-022-03902-y) (PMID:36271143) (PMCID:PMC9587232)

Baksmeier, C. et al. (2021) Modified recombinant human IgG1-Fc is superior to natural intravenous immunoglobulin at inhibiting immune-mediated demyelination. Immunology, 164(1), pp. 90-105. (doi: 10.1111/imm.13341) (PMID:33880776) (PMCID:PMC8358725)

Alexander, A. J.T. et al. (2020) Development of a reverse genetics system for Toscana virus (lineage A). Viruses, 12(4), 411. (doi: 10.3390/v12040411)